Literature DB >> 304104

Production of corticotrophin releasing hormone by the isolated hypothalamus of the rat.

J C Buckingham, J R Hodges.   

Abstract

1. The ability of the rat hypothalamus to produce corticotrophin releasing hormone (CRH) in vitro was studied in the presence and absence of neurotransmitter substances, angiotensin and corticosterone. 2. Acetylcholine, 5-hydroxytryptamine (5-HT) and angiotensin II increased hypothalamic CRH release and content. 3. Noradrenaline and glycine decreased the spontaneous release of CRH from the hypothalamus but neither of these substances affected hypothalamic CRH content. 4. Dopamine, GABA, adrenaline, melatonin, histamine, glutamic acid and corticosterone did not affect the basal CRH activity of the hypothalamus in vitro. 5. Noradrenaline, GABA and corticosterone reduced the acetylcholine- and 5-HT-induced increases in the release of CRH from the hypothalamus. The rises in CRH content induced by acetylcholine and 5-HT were also reduced by noradrenaline and GABA but increased by corticosterone. 6. The physiological significance of the results and the potential value of the technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304104      PMCID: PMC1353568          DOI: 10.1113/jphysiol.1977.sp012054

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Diurnal variations in plasma corticosterone and growth hormone as corrlelated with regional variations in norepinephrine, dopamine and serotonin content of rat brain.

Authors:  M L Simon; R George
Journal:  Neuroendocrinology       Date:  1975       Impact factor: 4.914

2.  Effect of adrenocortical hormones on activity of the serotoninergic system in limbic structures in rats.

Authors:  G Telegdy; I Vermes
Journal:  Neuroendocrinology       Date:  1975       Impact factor: 4.914

3.  The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors.

Authors:  J C Buckingham; J R Hodges
Journal:  J Endocrinol       Date:  1977-02       Impact factor: 4.286

4.  Changes in plasma corticosterone and hypothalamic CRF levels following intraventricular injection or drug-induced changes of brain biogenic amines in the rat.

Authors:  K Abe; T Hiroshige
Journal:  Neuroendocrinology       Date:  1974       Impact factor: 4.914

5.  Inhibitory action of serotonin on hypothalamus-induced ACTH release.

Authors:  I Vermes; G Telegdy; K Lissák
Journal:  Acta Physiol Acad Sci Hung       Date:  1972

6.  Inhibitory effect of L-dihydroxyphenylalanine on the venous 17-hydroxycorticosteroid response to surgical stress in dogs.

Authors:  G R Van Loon; L Hilger; A B King; A T Boryczka; W F Ganong
Journal:  Endocrinology       Date:  1971-06       Impact factor: 4.736

7.  Localization and specificity of corticosteroid "feedback receptors" at the hypothalamo-hypophyseal level; comparative effects of various steroids implanted in the median eminence or the anterior pituitary of the rat.

Authors:  B Bohus; D Strashimirov
Journal:  Neuroendocrinology       Date:  1970       Impact factor: 4.914

8.  Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man.

Authors:  H Imura; Y Nakai; T Yoshimi
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

9.  Effects of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release.

Authors:  G B Makara; E Stark
Journal:  Neuroendocrinology       Date:  1974       Impact factor: 4.914

10.  Stimulation electrically and by acetylcholine of the rat hypothalamus in vitro.

Authors:  M W Bradbury; J Burden; E W Hillhouse; M T Jones
Journal:  J Physiol       Date:  1974-06       Impact factor: 5.182

View more
  17 in total

1.  Pepsin secretion in the isolated rat stomach preparations [proceedings].

Authors:  K T Bunce; M Grewal; M E Parsons
Journal:  J Physiol       Date:  1979-11       Impact factor: 5.182

2.  Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease.

Authors:  Ali Iranmanesh; Dudley F Rochester; Jing Liu; Johannes D Veldhuis
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

3.  The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.

Authors:  J C Buckingham
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

Review 4.  Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

5.  The effects of some neurotransmitter substances on the production of corticotrophin releasing factor by the rat hypothalamus in vitro [proceedings].

Authors:  J C Buckingham; J R Hodges
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

6.  Energy expenditure of rats tube-fed at different energy levels [proceedings].

Authors:  G Armitage; G R Hervey; G Tobin
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

7.  Appearance of ATP in the coronary sinus effluent from isolated working rat heart in response to hypoxia [proceedings].

Authors:  M G Clemens; T Forrester
Journal:  J Physiol       Date:  1979-10       Impact factor: 5.182

8.  Central pharmacological control of corticosterone secretion in the intact rat. Demonstration of cholinergic and serotoninergic facilitatory and alpha-adrenergic inhibitory mechanisms.

Authors:  J A Steiner; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

9.  Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus.

Authors:  J C Buckingham; J H Leach
Journal:  J Physiol       Date:  1980-08       Impact factor: 5.182

10.  Release of beta-lipotropin- and beta-endorphin-like material induced by angiotensin in the conscious rat.

Authors:  U Beuers; G Hertting; W Knepel
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.